ClearPoint Neuro, Inc. (CLPT) Operating margin 2017–2025
ClearPoint Neuro, Inc. (CLPT) operating margin by fiscal year — reported operating income divided by reported revenue.
-65.4%FY2025 · since FY2017: -85.9% → -65.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -65.4% | -2.5 pp |
| FY2024 | -62.9% | +30.8 pp |
| FY2023 | -93.7% | -14.2 pp |
| FY2022 | -79.5% | +2.6 pp |
| FY2021 | -82.1% | -33.6 pp |
| FY2020 | -48.5% | -7.5 pp |
| FY2019 | -41.0% | +30.4 pp |
| FY2018 | -71.4% | +14.5 pp |
| FY2017 | -85.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLPT financial trends
CLPT RevenueCLPT Net incomeCLPT Net marginCLPT Gross profitCLPT Gross marginCLPT Operating incomeCLPT Operating cash flowCLPT Free cash flowCLPT Capital expendituresCLPT Return on equityCLPT Stock buybacksCLPT Dividends paidCLPT Total assetsCLPT Total liabilitiesCLPT Shareholders’ equityCLPT overview →